Black and African Americans Connections to Parkinson's Disease (BLAAC PD)

Recruiting

• Conditions: Parkinson Disease

• Registration Number: NCT06719583
• Lead Sponsor: Michael J. Fox Foundation for Parkinson's Research

Brief Summary

BLAAC PD is a research study to understand what Parkinson's disease looks like for Black and African American communities.

BLAAC PD is happening at research centers around the United States. The study is part of the Global Parkinson's Genetics Program (GP2). GP2 is a research project working to transform understanding of the genetics of Parkinson's disease and make that knowledge globally relevant.

Detailed Description

Research studies have found connections between genes and Parkinson's disease (PD). But those results have mostly come from studies with non-Black or African American volunteers. BLAAC PD aims to learn more about gene changes that may cause Parkinson's in Black and African American people. Study volunteers at sites across the United States will attend one visit and will give either a blood or saliva sample, complete a smell test, and may be asked to complete a physical exam. This new data could lead to future Parkinson's tests and treatments for Black and African American people and it may help better understand disease in other groups, too.

This pioneering initiative will fill a gap of knowledge about PD in Black and African American people.

Study Timeline

• Study Start: 2020-11-16
• Status Verified: 2024-12
• Study First Submitted: 2024-12-02
• Study First Submitted QC: 2024-12-02
• Last Update Submitted: 2024-12-02
• Study First Posted: 2024-12-06
• Last Update Posted: 2024-12-06
• Primary Completion: 2026-12-31
• Study Completion: 2026-12-31

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 2000

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Explore novel risk factors and characterization	5 years	To explore novel risk factors and characterization of known genetic risk factors contributing to Parkinson's disease risk in the Black and African American population.

Trial Locations

Locations (12)

University of Alabama at Birmingham; 🇺🇸 Birmingham, Alabama, United States

University of Florida; 🇺🇸 Gainesville, Florida, United States

Rush University; 🇺🇸 Chicago, Illinois, United States

University of Chicago; 🇺🇸 Chicago, Illinois, United States

Ochsner Clinic Foundation; 🇺🇸 New Orleans, Louisiana, United States

Louisiana State University Health Sciences Center Shreveport; 🇺🇸 Shreveport, Louisiana, United States

University of Maryland; 🇺🇸 Baltimore, Maryland, United States

Kaiser Permanente Midatlantic States; 🇺🇸 Rockville, Maryland, United States

Washington University in St. Louis; 🇺🇸 Saint Louis, Missouri, United States

University Hospitals Cleveland Medical Center; 🇺🇸 Cleveland, Ohio, United States

Scroll for more (2 remaining)